How does ketamine actually work as a treatment for depression and other mental health conditions? Dr. Dom explains in this interview.
10:20 min
CLEAR ALL
Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.
1
A collaboration between MAPS and the Centre for Psychedelic Research at Imperial College London, Antwan Saca, Leor Roseman, Ph.D., and Natalie Ginsberg, M.S.W.
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.
Part of the way healing occurs during the ketamine infusion is due to the non-ordinary (psychedelic) experience. In this non-ordinary state, the unconscious mind is accessed and allows processing of unresolved emotions and traumatic events.
Once deemed dangerous and illegal, psychedelic compounds have been rediscovered by the scientific, medical and psychiatric communities as research reveals their capacity to help patients with a range of maladies.
How could LSD and psilocybin help with mental health, palliative care and addictive behaviours? What was the point of a psilocybin mushroom evolving the way that it did? Michael Pollan explores the “second wave” of international research and discusses what psychedelic drugs may teach us about...
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.